- This event has passed.
Roundtable Discussion for Health Centers: Ensuring Diverse and Inclusive COVID-19 Clinical Trials through Health Center Engagement in the ACTIV-2 Clinical Trial
October 15, 2020 @ 5:00 pm - 6:00 pm
The ACTIV-2 Study, part of Operation Warp Speed, is a treatment study testing the efficacy and safety of monoclonal antibodies. While vaccine trials are currently garnering much media attention, we are calling on health centers early – before a treatment is available – to be part of the effort to find a cure.
On October 15th, join stakeholders from HRSA, ACTIV-2, the community, and study sites to learn about the study, its progress and importance, and how health centers can get involved. Panelists will be prepared to answer your questions.
To learn more about the ACTIV-2 Study and the Rise Above COVID movement, visit: RiseAboveCOVID.org